Werba Rubin Papier Wealth Management

Position in GILD — Gilead Sciences, Inc.

CIK 1971029 SAN JOSE, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,105,348

-$84,453 QoQ

Shares Held

8,749

+2.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.57%

of 13F equity value

Holder Rank

#1,027

of 2,266 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Werba Rubin Papier Wealth Management holds $6,239,917 across 8 Drug Manufacturers - General names. GILD ranks #2 (17.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,280	$1,535,270
2	GILD	Gilead Sciences, Inc. This page	8,749	$1,105,348
3	JNJ	Johnson & Johnson	4,317	$1,096,388
4	ABBV	AbbVie Inc.	4,226	$1,063,430
5	MRK	Merck & Co., Inc.	5,214	$669,999
6	AMGN	Amgen Inc	800	$289,696
7	PFE	Pfizer Inc	10,583	$254,838
8	BMY	Bristol Myers Squibb Co	3,904	$224,948

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,105,348	8,749	+2.5%	Shares	Sole	2026-07-28
2026-03-31	$1,189,801	8,537	+4.0%	Shares	Sole	2026-05-12
2025-12-31	$1,007,572	8,209	+3.4%	Shares	Sole	2026-01-27
2025-09-30	$881,562	7,942	-0.2%	Shares	Sole	2025-11-04
2025-06-30	$882,081	7,956	+1.0%	Shares	Sole	2025-07-29
2025-03-31	$882,505	7,876	-0.5%	Shares	Sole	2025-05-07
2024-12-31	$731,200	7,916	-43.8%	Shares	Sole	2025-02-03
2024-09-30	$1,181,724	14,095	+2.7%	Shares	Sole	2024-10-18
2024-06-30	$941,878	13,728	+1.8%	Shares	Sole	2024-08-06
2024-03-31	$987,849	13,486	+0.2%	Shares	Sole	2024-05-01
2023-12-31	$1,090,637	13,463	-0.4%	Shares	Sole	2024-01-22
2023-09-30	$1,012,814	13,515	—	Shares	Sole	2023-11-06
No filing history on record for this holder in this stock.